Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
ANIP

Price
78.90
Stock movement down
-2.00 (-2.76%)
Company name
ANI Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
1.58B
Ent value
2.20B
Price/Sales
1.79
Price/Book
2.93
Div yield
-
Div growth
-
Growth years
-
FCF payout
1.02%
Trailing P/E
20.87
Forward P/E
6.78
PEG
-
EPS growth
-
1 year return (CAGR)
11.43%
3 year return (CAGR)
17.79%
5 year return (CAGR)
18.36%
10 year return (CAGR)
7.19%
Last updated: 2026-03-13

DIVIDENDS

ANIP does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E20.87
Price to OCF8.55
Price to FCF13.93
Price to EBITDA7.32
EV to EBITDA10.16

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales1.79
Price to Book2.93
EV to Sales2.49

FINANCIALS

Per share

Loading...
Per share data
Current share count22.46M
EPS (TTM)3.57
FCF per share (TTM)5.35

Income statement

Loading...
Income statement data
Revenue (TTM)883.37M
Gross profit (TTM)610.19M
Operating income (TTM)111.09M
Net income (TTM)75.85M
EPS (TTM)3.57
EPS (1y forward)10.39

Margins

Loading...
Margins data
Gross margin (TTM)69.08%
Operating margin (TTM)12.58%
Profit margin (TTM)8.59%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash285.58M
Net receivables281.08M
Total current assets753.12M
Goodwill62.48M
Intangible assets479.53M
Property, plant and equipment0.00
Total assets1.44B
Accounts payable62.58M
Short/Current long term debt325.19M
Total current liabilities278.11M
Total liabilities899.65M
Shareholder's equity540.72M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)185.22M
Capital expenditures (TTM)56.78M
Free cash flow (TTM)113.64M
Dividends paid (TTM)1.16M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity14.03%
Return on Assets5.27%
Return on Invested Capital13.59%
Cash Return on Invested Capital20.37%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open72.62
Daily high72.90
Daily low70.15
Daily Volume518K
All-time high375.84
1y analyst estimate110.63
Beta0.46
EPS (TTM)3.57
Dividend per share0.00
Ex-div date-
Next earnings date26 Feb 2026

Downside potential

Loading...
Downside potential data
ANIPS&P500
Current price drop from All-time high-79.01%-1.82%
Highest price drop-98.57%-56.47%
Date of highest drop25 Jun 20139 Mar 2009
Avg drop from high-77.47%-10.84%
Avg time to new high406 days12 days
Max time to new high5356 days1805 days
COMPANY DETAILS
ANIP (ANI Pharmaceuticals Inc) company logo
Marketcap
1.58B
Marketcap category
Small-cap
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Employees
897
Investor relations
-
SEC filings
CEO
Arthur S. Przybyl
Country
USA
City
Baudette
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...